News

“Our second quarter results demonstrate the strength of our business model with its strong recurring revenue and cash flow,” stated Gioacchino De Chirico, president and chief executive officer.

Through its subsidiary UPS Supply Chain Solutions, United Parcel Service (UPS) said that it has assumed control of two key Merck distribution centers, which provide Merck with temperature-sensitive

In this role, Mr Mengler will be responsible for expanding the company’s generic business by growing capability in the US market while driving global opportunities. Mr Mengler comes

Mr Byle is presently vice-president of technology for Dockwise, a public, international company, where he is in charge of its R&D program and intellectual property portfolio. Michael Cohen,

Bayer Schering Pharma has programs for cancer, cardiovascular diseases and gynecological therapies and GeneGo has good coverage of these diseases and others, said GeneGo. GeneGo is also in

This agreement will give Centocor and its Ortho Biotech Oncology R&D division affiliates the opportunity to discover and develop novel small molecule inhibitors of the fatty acid biosynthesis

Dr Egeler is a pediatric bone marrow transplantation physician and an internationally recognized authority in pediatric hemato-oncology. He brings to Kiadis Pharma over more than 20 years of

The company’s board of directors has approved a plan of complete liquidation and dissolution of the company (the plan), subject to shareholder approval. The company intends to hold

Star technology is a production technology that is particularly useful for the production of recombinant human antibodies and proteins. It has a potentially broad application and is reported